Advertise With Us

Medicircle is India's leading Healthcare portal dedicated to Doctors & Healthcare professionals with over 4,50,000 registered newsletter subscribers and over 6,00,000 page views & 2,00,000 unique visitors every month.
Backed by a team of dynamic Healthcare Professionals who have joined hands with Media Veterans having done pioneering work with India's leading Media Brands.
The Medicircle team strives to connect the medical community across the length & breadth of the country and gets inspired from the Global Trends & Technology.
Medicircle gives you an opportunity to feature your brands, products, services on our platform connecting with you to the Doctors, Entrepreneurs, Startups, Venture Capitalists, Incubators, and SME owners. We create seamless solutions for Pharmaceutical & manufacturers Brands in launching new drugs & maintaining brand position.
We also create engaging dialogues, Customised Mailers, Sms & Whatsapp Campaigns, workshops & events for getting your message to the relevant audience.
Our Reader Profile: We can show pie-chart showing reader category (Optional)
For Advertising with us, Please mail us as sales@medicircle.in or Call on 91-7304433234
For Content Tie-ups & Brand Alliance, please mail editor@medicircle.in

-Advertisements-





Trending Now

Revive Therapeutics collaborates with North Carolina State University to develop PsilocybinJanuary 16, 2021
Knopp Biosciences announces results from the phase 2 EXHALE trial of oral Dexpramipexole Eosinophilic AsthmaJanuary 16, 2021
India's fight against COVID 19 is one of self-confidence and self-reliance, asserts Prime MinisterJanuary 16, 2021
UK to close all travel corridors from Monday to keep out new COVID strainsJanuary 16, 2021
Janssen received U.S. FDA approval for DARZALEX FASPROJanuary 16, 2021
Six EU countries say 'situation unacceptable' after Pfizer-BioNTech slows vaccine deliveriesJanuary 16, 2021
Scientists tackle vaccine safety, efficacy and access at global R&D forumJanuary 16, 2021
Jubilant Therapeutics Announces Research Collaboration with The Wistar Institute to Evaluate the Activity of Novel PAD4 InhibitorsJanuary 16, 2021
COVID-19 vaccines: Common solution, not competitionJanuary 16, 2021
Hyper-Transmissible SARS-CoV-2 Variant Detected in United States WastewaterJanuary 16, 2021
Maharashtra reports 3,145 new COVID-19 casesJanuary 16, 2021
Delhi reports 295 new cases of COVID-19 in last 24 hoursJanuary 16, 2021
Delhi reports 295 new cases of COVID-19 in last 24 hoursJanuary 16, 2021
Government confirms spread of Bird flu in 11 statesJanuary 16, 2021
Healthy recipe for evening snackJanuary 16, 2021
China facing severe outbreak in Hebei and Heilongjiang provincesJanuary 16, 2021
Dr Reddy's granted approval for 3rd stage Human Trials from DCGI : Russian Sputnik V vaccineJanuary 16, 2021
Prime Minister Narendra Modi to launch world’s largest COVID-19 vaccination program this morningJanuary 16, 2021
Vaibhav Tewari Co-founder, and COO, Portea Medical on making Portea - Asia’s largest and fastest-growing at-home quality healthcare provider January 16, 2021
PFIZER’S XALKORI APPROVED BY USFDA FOR ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA IN CHILDREN AND YOUNG ADULTSJanuary 15, 2021